Next Science Limited
NXSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $22,816 | $22,179 | $11,713 | $8,948 |
| % Growth | 2.9% | 89.4% | 30.9% | – |
| Cost of Goods Sold | $4,373 | $5,945 | $4,991 | $2,702 |
| Gross Profit | $18,443 | $16,235 | $11,905 | $5,939 |
| % Margin | 80.8% | 73.2% | 101.6% | 66.4% |
| R&D Expenses | $6,579 | $6,486 | $6,150 | $5,047 |
| G&A Expenses | $6,752 | $5,610 | $5,385 | $4,106 |
| SG&A Expenses | $22,820 | $25,776 | $15,695 | $11,501 |
| Sales & Mktg Exp. | $16,067 | $20,165 | $10,310 | $7,395 |
| Other Operating Expenses | -$651 | -$73 | $8,373 | -$1,331 |
| Operating Expenses | $28,748 | $32,189 | $30,218 | $15,217 |
| Operating Income | -$10,304 | -$15,954 | -$12,703 | -$9,278 |
| % Margin | -45.2% | -71.9% | -108.5% | -103.7% |
| Other Income/Exp. Net | -$282 | -$317 | $20 | $241 |
| Pre-Tax Income | -$10,586 | -$16,271 | -$12,683 | -$9,037 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,586 | -$24,513 | -$18,296 | -$9,029 |
| % Margin | -46.4% | -110.5% | -156.2% | -100.9% |
| EPS | -0.036 | -0.07 | -0.087 | -0.048 |
| % Growth | 47.8% | 20% | -82.9% | – |
| EPS Diluted | -0.036 | -0.07 | -0.087 | -0.048 |
| Weighted Avg Shares Out | 291,634 | 234,095 | 210,468 | 196,883 |
| Weighted Avg Shares Out Dil | 291,896 | 234,095 | 210,468 | 196,883 |
| Supplemental Information | – | – | – | – |
| Interest Income | $107 | $419 | $13 | $16 |
| Interest Expense | $284 | $736 | $28 | $16 |
| Depreciation & Amortization | $1,273 | $1,113 | $882 | $372 |
| EBITDA | -$9,029 | -$14,422 | -$11,776 | -$9,219 |
| % Margin | -39.6% | -65% | -100.5% | -103% |